Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 31NETWORK 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Colorectal Neoplasms 14Prostatic Neoplasms 13Head and Neck Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Sarcoma 10Neoplasms 9Ovarian Neoplasms 8Uterine Cervical Neoplasms 7Rectal Neoplasms 7Lymphoma 7Lung Neoplasms 7Leukemia 7Colonic Neoplasms 7Urinary Bladder Neoplasms 6Stomach Neoplasms 6Pain 6Neoplasm Metastasis 6Fallopian Tube Neoplasms 6Hodgkin Disease 5Burkitt Lymphoma 5Breast Carcinoma In Situ 5Brain Neoplasms 5Testicular Neoplasms 4Teratoma 4Squamous Cell Carcinoma of Head and Neck 4Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × NETWORK × COVID-19 × Clear all
NCT05386355 2025-03-11

MoVeUP

IDeA States Pediatric Clinical Trials Network

Phase NA Completed
1,934 enrolled 11 charts
LymphoidOther hematologic neoplasm

COVID-19, Vaccination Hesitancy, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04805203 2023-10-19

Covimmunomm

Intergroupe Francophone du Myelome

Phase NA Terminated
139 enrolled
Plasma cell

COVID-19, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡